Rankings
▼
Calendar
PEN
Penumbra, Inc.
$13B
FY 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$1.2B
+12.9% YoY
Gross Profit
$755M
63.2% margin
Operating Income
$9M
0.8% margin
Net Income
$14M
1.2% margin
EPS (Diluted)
$0.36
Cash Flow
Operating Cash Flow
$168M
Free Cash Flow
$147M
Stock-Based Comp.
$46M
Balance Sheet
Total Assets
$1.5B
Total Liabilities
$382M
Stockholders' Equity
$1.2B
Cash & Equivalents
$324M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.2B
$1.1B
+12.9%
Gross Profit
$755M
$683M
+10.6%
Operating Income
$9M
$74M
-87.4%
Net Income
$14M
$91M
-84.6%
← Q4 2023
All Quarters
Q1 2024 →
PEN FY 2024 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena